FONAR Corporation (FONR)
NASDAQ: FONR · Real-Time Price · USD
18.48
-0.01 (-0.05%)
At close: Mar 9, 2026, 4:00 PM EDT
18.50
+0.02 (0.11%)
After-hours: Mar 9, 2026, 4:00 PM EDT
FONAR Market Cap
FONAR has a market cap or net worth of $121.15 million as of March 9, 2026. Its market cap has increased by 25.02% in one year.
Market Cap
121.15M
Enterprise Value
107.85M
1-Year Change
25.02%
Ranking
Category
Stock Price
$18.48
Market Cap Chart
Since December 1, 1998, FONAR's market cap has increased from $107.60M to $121.15M, an increase of 12.59%. That is a compound annual growth rate of 0.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 121.20M | -0.82% |
| Dec 31, 2025 | 122.20M | 21.35% |
| Dec 31, 2024 | 100.70M | -24.68% |
| Dec 29, 2023 | 133.70M | 15.36% |
| Dec 30, 2022 | 115.90M | 11.55% |
| Dec 31, 2021 | 103.90M | -12.39% |
| Dec 31, 2020 | 118.60M | -11.82% |
| Dec 31, 2019 | 134.50M | -1.39% |
| Dec 31, 2018 | 136.40M | -16.01% |
| Dec 29, 2017 | 162.40M | 29.61% |
| Dec 30, 2016 | 125.30M | 12.88% |
| Dec 31, 2015 | 111.00M | 65.92% |
| Dec 31, 2014 | 66.90M | -50.66% |
| Dec 31, 2013 | 135.60M | 372.47% |
| Dec 31, 2012 | 28.70M | 163.30% |
| Dec 30, 2011 | 10.90M | 43.42% |
| Dec 31, 2010 | 7.60M | -13.64% |
| Dec 31, 2009 | 8.80M | 91.30% |
| Dec 31, 2008 | 4.60M | -84.19% |
| Dec 31, 2007 | 29.10M | -20.71% |
| Dec 29, 2006 | 36.70M | -54.91% |
| Dec 30, 2005 | 81.40M | -53.00% |
| Dec 31, 2004 | 173.20M | 53.41% |
| Dec 31, 2003 | 112.90M | 25.58% |
| Dec 31, 2002 | 89.90M | 8.57% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 820.31M |
| Castle Biosciences | 806.31M |
| Myriad Genetics | 481.57M |
| Fulgent Genetics | 456.90M |
| Prenetics Global | 299.55M |
| Burning Rock Biotech | 239.56M |
| Biodesix | 185.14M |
| Insight Molecular Diagnostics | 175.31M |